Stock Market News
Cambridge Cognition announces mental health assessment software
AIM-listed digital neuroscience company Cambridge Cognition has been working on a new software product to assess mental health and well-being at work.
CANTAB BrainHealth is a digital health product designed for occupational health professionals aimed at measuring and monitoring mental well-being and cognitive performance in the workplace
Cambridge Cognition expects to work closely with channel partners, initially in the US and the UK, to commercialise its proprietary cognitive assessment technology.
The firm claims its new product can accurately measure cognition and mood objectively, identifying signs of an underlying brain health condition early.
Dr Jenny Brockis, an independent brain health and workplace performance consultant said, "The objective mood and cognition assessments are sensitive to the potential presence of an underlying mental health condition, facilitating early intervention before productivity and performance are impacted."
Dr Steven Powell, Cambridge Cognition's chief executive, added, "We are delighted to announce this important digital health product, building on the success of our gold standard technologies used in over one million clinical trial assessments. CANTAB BrainHealth software will be licensed globally to occupational health providers and channel partners, offering an urgent solution for employers and enabling their employees to thrive."
As of 1650 BST, Cambridge Cognition shares had dipped 0.59% to 168p.
CANTAB BrainHealth is a digital health product designed for occupational health professionals aimed at measuring and monitoring mental well-being and cognitive performance in the workplace
Cambridge Cognition expects to work closely with channel partners, initially in the US and the UK, to commercialise its proprietary cognitive assessment technology.
The firm claims its new product can accurately measure cognition and mood objectively, identifying signs of an underlying brain health condition early.
Dr Jenny Brockis, an independent brain health and workplace performance consultant said, "The objective mood and cognition assessments are sensitive to the potential presence of an underlying mental health condition, facilitating early intervention before productivity and performance are impacted."
Dr Steven Powell, Cambridge Cognition's chief executive, added, "We are delighted to announce this important digital health product, building on the success of our gold standard technologies used in over one million clinical trial assessments. CANTAB BrainHealth software will be licensed globally to occupational health providers and channel partners, offering an urgent solution for employers and enabling their employees to thrive."
As of 1650 BST, Cambridge Cognition shares had dipped 0.59% to 168p.
Related share prices |
---|
Cambridge Cognition Holdings (COG) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price